Exciting Instruments' single-molecule detection platform brings the ultimate resolution to life science experiments across research, drug development and medical diagnostics.
We are on a mission to bring the power of single-molecule detection and characterisation to every lab
We envision a new era where single-molecule insights become the foundation for breakthroughs in basic science, drug development, and diagnostics.
Tim Craggs, CEO of Exciting Instruments, is a leader in the field of single-molecule fluorescence. With extensive multidisciplinary experience spanning chemistry, physics and biology he has held research positions at Cambridge, St Andrews, Yale, Oxford, Bristol, and Sheffield. Craggs founded Exciting Instruments to democratize advanced single-molecule detection methods for applications in biophysics, drug discovery and diagnostics.
Robert Bell is a technologist and business operator with a background in startups and consulting. Prior to founding Exciting Instruments he was co-founder of an AI analytics startup and provided technology consultancy across a broad range of industries.